INTRODUCTION
Hemophagocytic lymphohistiocytosis (HLH) is a potentially lethal immune system dysregulation in children and adults.1 Failure to properly inhibit the immune response leads to constant and excessive activity of the cytotoxic T-cells, natural killer (NK) cells, and macrophages. Inflammatory reactions caused by the intense activity of the cellular immune system and cytokine storm in tissues lead to multiple organ failure in this disease.2
HLH is categorized as primary, which is defined as the presence of a predisposing genetic mutation in the immune system, and reactive to an infectious, inflammatory, or malignant trigger.3 The diagnosis is challenging as it has no clinical or laboratory pathognomonic features. Fever, organomegaly, liver dysfunction, cytopenias, coagulopathy, hemophagocytosis, and neurologic dysfunction are common manifestations of HLH.1
Ocular involvement is relatively rare in HLH. Unilateral panuveitis, Purtscher retinopathy, trabecular meshwork involvement, and choroidal infiltration with secondary extension to the retina and optic nerve head (ONH) have been reported previously.4
This report aims to introduce a child with HLH and bilateral ONH infiltration.
CASE REPORT
A 9-year-old boy, with a history of HLH from January this year, was referred by his pediatric oncologist to the ophthalmic emergency department with a complaint of painless progressive blurred vision in his right eye. On ocular external examination, there was a mild conjunctival injection, chemosis, and proptosis in his right eye (Figure 1). The best-corrected distance visual acuity was 20/40 and 20/20 for his right and left eye respectively. The relative afferent pupillary defect (RAPD) examination was positive for the right eye. Anterior segment examination was unremarkable for both eyes. In the fundus examination, we found an optic disc swelling and peripapillary hemorrhage in the right eye. The left fundus examination showed a mild ONH blurred margin. Regarding the patient's clinical status, differential diagnoses include neoplastic infiltrative optic neuropathy, cytomegalovirus (CMV) optic neuritis, drug toxicity, and CNS involvement with increased intracranial pressure (ICP). For further evaluation, a brain and orbital MRI with gadolinium enhancement (Figure 3), aqueous sampling with a 25-gauge needle for polymerase chain reaction (PCR) to detect CMV, lumbar puncture (LP) to analyze cerebrospinal fluid cytology and biochemistry, and also for ICP measurement, and blood test for hematology and biochemistry were ordered. The results of the patient's imaging and lab tests are summarized in Table 1.
[IMAGE OMITTED. SEE PDF]
TABLE 1 laboratory test results.
| Laboratory test | Result |
| Cerebrospinal fluid biochemistry | |
| Sugar | 44 mg/dL |
| Protein | 98.5 |
| Cholesterol | 1 mg/dL |
| LDH | 35 U/L |
| CSF analysis: mildly increasing lymphomononuclear cells | |
| Complete blood cell analysis and cell differentiation | |
| white blood cell | 5.4 |
| Red blood cell | 2.8 |
| Hemoglobin | 7.2 |
| Hematocrit | 22 |
| MCV | 76 |
| MCH | 25 |
| MCHC | 32.7 |
| Platelet | 89 |
| PMN | 75 |
| Lymphocyte | 25 |
| Glucose | 115 mg/dL |
| Urea | 29 mg/dL |
| Creatinine | 0.4 mg/dL |
| AST | 32 U/L |
| ALT | 40 U/L |
| Calcium | 9.3 mg/dL |
| Sodium | 141 meq/L |
| Potassium | 3.8 |
| CRP | 5 mgr/dl |
| ESR | 55 MM |
In the first week of July, in the first follow-up examination, the optic disc swelling progressed (Figure 2) in both eyes and the visual acuity decreased dramatically to light perception in the right eye and 20/40 in the left eye. The patient was referred to his oncologist to continue systemic chemotherapy and radiotherapy. In the last follow-up visit, the fundus examination revealed disc swelling, retinal edema and epiretinal hemorrhage in both eyes, and visual acuity deteriorated to no light perception and counting fingers in the right and left eye, respectively.
[IMAGE OMITTED. SEE PDF]
[IMAGE OMITTED. SEE PDF]
[IMAGE OMITTED. SEE PDF]
DISCUSSION
In this study, we reported a child with HLH presented to us with bilateral painless progressive visual loss. In the ophthalmic examination, we found bilateral optic disc swelling and hemorrhage. HLH is an immune system dysregulation characterized by multiorgan infiltration of macrophages, especially affecting the liver, spleen, lungs, bone marrow, lymph nodes, and kidneys leading to various signs and symptoms. The mean age of occurrence is 1.8 in children and 50 years old in adults.3
Ocular involvement is uncommon in HLH. Wang et al., in a study in 2023, showed that old age, autoimmune disorders, and decreasing RBC and platelet counts are independent risk factors of ocular involvement in HLH.4 Retinal hemorrhage, conjunctivitis, corneal infiltration, anterior uveitis, papillitis, and choroidal involvement are the main ophthalmic signs in these patients.4 A brief literature review from 2005 to 2023, including five case reports, one case series, and a retrospective analysis, regarding ocular involvement in HLH is summarized in Table 2.
TABLE 2 Summary of previous studies regarding ocular involvement in HLH.
| Study | Year | Type | Age of patient(s) | Gender | Findings in patient(s) with HLH |
| Xu Li et al.9 | 2017 | Case report | 53 years old | Male |
Unilateral panuveitis |
| Sebrow et al.10 | 2017 | Case report | 52 years old | Female |
Purtscher retinopathy |
| Suhr et al.11 | 2016 | Case report | 1 month old | Female |
Bilateral retinal white dot lesions which showed increased pigmentation over the next months. |
| Wang et al.4 | 2023 | Retrospective analysis | 133 patients with a mean age of 30.21 ± 14.42. | - |
Retinal/vitreous hemorrhage is the most common ocular finding in patients with HLH, followed by conjunctivitis, keratitis, anterior uveitis, and optic disc swelling. |
| Viscaino et al.12 | 2017 | Case series | Three adult patients | Male |
Pathologic evaluation revealed a bilateral uveal histiocytic infiltration with secondary involvement of the retina, optic nerve head, and trabecular meshwork. |
| Engelbert et al.13 | 2007 | Case report | 1 month old | Female |
A one-month-old female with HLH, presented with bilateral posterior pole white dots predominantly involving the outer retina and choriocapillaris. |
| Chong et al.14 | 2012 | Case report | Eight months old | Female |
An eight-month-old girl with HLH presented with central nervous system involvement and optic nerve infiltration. |
ONH involvement in HLH is rare. A wide range of differential diagnoses should be considered.5 We summarized the clinical approach to our patient in Figure 4. Regarding the patient's immune status, opportunistic infections such as CMV optic neuritis and retinitis must be investigated and ruled out. Ocular involvement in CMV infection is a serious sight-threatening condition that could be manifested as ONH inflammation.6 Diagnosis of ocular CMV infection is clinical, although in atypical cases aqueous fluid PCR is diagnostic.7 The sensitivity and specificity of PCR tests for aqueous samples are 82% and 91%, respectively. The result of the aqueous and blood PCR tests was negative in our patient and we found no evidence of systemic CMV infection. In the brain and orbital MRI, we found bilateral optic nerve infiltration and the CSF analysis showed the brain involvement with tumoral cells. CNS involvement with infiltrative tumors can lead to increased ICP followed by bilateral ONH swelling. However, ICP was within normal limits. Another differential diagnosis in this patient is an adverse drug complication. There are reports of etoposide-related optic nerve toxicity.8 However, clinical evidence and imaging findings indicate optic neuropathy due to tumoral infiltration, not drug toxicity.
AUTHOR CONTRIBUTIONS
Farid Shekarchian: Investigation; supervision; writing – review and editing. Mitra Karimi Amir Abadi: Data curation; writing – original draft. Mehrdad Motamed Shariati: Investigation; supervision; writing – original draft; writing – review and editing.
ACKNOWLEDGMENTS
None.
FUNDING INFORMATION
The authors received no funding. The author's work is not funded by the government or academic institutes.
CONFLICT OF INTEREST STATEMENT
The authors declare that they have no competing interests.
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
ETHICS STATEMENT
Not applicable.
CONSENT
Written informed consent was obtained from the patient's legal guardian to publish this report in accordance with the journal's patient consent policy.
Al‐Samkari H, Berliner N. Hemophagocytic lymphohistiocytosis. Ann Rev Pathol. 2018;13:27‐49.
George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med. 2014;5:69‐86.
Ponnatt TS, Lilley CM, Mirza KM. Hemophagocytic lymphohistiocytosis. Arch Pathol Lab Med. 2022;146(4):507‐519.
Wang L, Suo L, Kou F, et al. Ocular phenotypes in patients with hemophagocytic Lymphohistiocytosis: a retrospective analysis in a single center over 7 years. Am J Ophthalmol. 2023;253:119‐131.
Margolin E. The swollen optic nerve: an approach to diagnosis and management. Pract Neurol. 2019;19(4):302‐309.
Melancia D, Fernandes A, Manita M, Cordeiro IM. Cytomegalovirus optic neuropathy in a young immunocompetent patient. J Neurovirol. 2021;27:364‐366.
Ude IN, Yeh S, Shantha JG. Cytomegalovirus retinitis in the highly active anti‐retroviral therapy era. Annals Eye Sci. 2022;7:7.
Golombek T, Henker R, Rehak M, Quäschling U, Lordick F, Knödler M. A rare case of mixed adenoneuroendocrine carcinoma (MANEC) of the gastroesophageal junction with HER2/neu overexpression and distinct orbital and optic nerve toxicity after intravenous administration of cisplatin. Oncol Res Treat. 2019;42(3):123‐127.
Li X, Ma Y, Tang J, Chen T, Ma X. A hemophagocytic lymphohistiocytosis patient that presented with unilateral panuveitis. Ocul Immunol Inflamm. 2017;25(2):275‐277.
Sebrow DB, Dhrami‐Gavazi E, Horowitz JD, Yannuzzi LA. Purtscher retinopathy as a manifestation of hemophagocytic lymphohistiocytosis. Retinal Cases Brief Reports. 2017;11(4):335‐338.
Suhr KS, Chiang MF, Flynn JT, Engelbert M. Ocular involvement in hemophagocytic syndrome: a novel funduscopic manifestation and review of the literature. Retinal Cases Brief Rep. 2016;10(4):345‐348.
Vizcaino MA, Eberhart CG, Rodriguez FJ. Hemophagocytic lymphohistiocytosis in adults with intraocular involvement: clinicopathologic features of 3 cases. Ocular Oncol Pathol. 2017;4(1):1‐11.
Engelbert M, Chiang M, Flynn J. Is eye involvement in hemophagocytic lymphohistiocytosis (HLH) an ominous prognostic sign? Presentation of a novel funduscopic picture and review of the literature. Invest Ophthalmol Vis Sci. 2007;48(13):5168.
Chong KW, Lee JH, Choong CT, et al. Hemophagocytic lymphohistiocytosis with isolated central nervous system reactivation and optic nerve involvement. J Child Neurol. 2012;27(10):1336‐1339.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Key Clinical Message
Infiltrative optic neuropathy in hemophagocytic lymphohistiocytosis is rare but could potentially lead to visual loss. Cytomegalovirus (CMV) optic neuritis, drug toxicity, and CNS involvement with increased intracranial pressure (ICP) are differential diagnoses that have to be considered.
In this report, we introduced a known case of hemophagocytic lymphohistiocytosis (HLH) with progressive visual loss due to bilateral optic nerve head (ONH) involvement. A 9‐year‐old boy with a history of HLH from 6 months ago was referred to the ophthalmic emergency department with a complaint of painless progressive blurred vision in his right eye. The fundus examination found an optic disc swelling and peripapillary hemorrhage in the right eye. The left fundus examination showed a mild ONH blurred margin. Systemic evaluations including brain and orbital MRI with gadolinium enhancement and CSF analysis showed optic nerve and brain involvement with tumoral cells. Despite systemic chemotherapy with etoposide, the disease had a progressive course so in the last follow‐up visit, fundus examination revealed disc swelling, retinal edema, and epiretinal hemorrhage in both eyes and visual acuity deteriorated to no light perception and counting fingers in the right and left eye, respectively. ONH involvement in HLH is rare but could be sight‐threatening. Differential diagnoses that should be investigated include neoplastic infiltrative optic neuropathy, cytomegalovirus (CMV) optic neuritis, drug toxicity, and CNS involvement with increased intracranial pressure (ICP).
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer





